Rheumatoid Arthritis Clinical Trials in Los Angeles

Showing 1881-1900 of 2,731 trials

Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children

NCT02182986

Solid organ transplantation is an important therapeutic option for children with a variety of end stage diseases. However, the same immunosuppressive medications that are required to prevent the child's immune system from attacking and rejecting the transplanted organ can predispose these individuals to developing a very serious cancer that is linked to Epstein-Barr virus (EBV).

Heart TransplantSmall Intestine TransplantKidney Transplant+3 more

National Institute of Allergy and Infectious Diseases (NIAID)944 participantsStarted Aug 2014

Los Angeles, California, United States • Stanford, California, United States • Washington D.C., District of Columbia, United States +4 more locations

COMPLETEDPhase 3< 1 mile

An Extension Study to Evaluate the Long-Term Safety and Tolerability of Ubrogepant in the Treatment of Migraine

NCT02873221

This study will evaluate the long-term safety and tolerability of intermittent treatment with ubrogepant for the acute treatment of migraine over 1 year.

Migraine, With or Without Aura

Allergan1,254 participantsStarted Sep 2016

Birmingham, Alabama, United States • Chandler, Arizona, United States • Mesa, Arizona, United States +174 more locations

Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children

An Extension Study to Evaluate the Long-Term Safety and Tolerability of Ubrogepant in the Treatment of Migraine

Rheumatoid Arthritis Trials in Other Cities

A Phase IIb Study for ALX-0061 Monotherapy in Subjects With Rheumatoid Arthritis

Trastuzumab in Treating Patients With Locally Advanced or Metastatic Gallbladder Cancer or Bile Duct Cancer That Cannot Be Removed by Surgery

Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis

A Study of Disease Progression in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

BOTOX® Open-Label Treatment in Pediatric Lower Limb Spasticity

An Extension Study to Evaluate the Long-Term Safety of Lampalizumab in Participants With Geographic Atrophy

Positive Imaging Study for Distant Metastases in Patients With Castration-Resistant Prostate Cancer

Safety and Preliminary Efficacy Study of NeoFuse in Subjects Undergoing Multi-Level Anterior Cervical Discectomy

A Safety and Efficacy Study of Tavilermide (MIM-D3) Ophthalmic Solution for the Treatment of Dry Eye Disease

NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed

Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer

A Study of Lampalizumab Intravitreal Injections Administered Every Two Weeks or Every Four Weeks to Participants With Geographic Atrophy

Soft Contacts Observation of Risk and Education (SCORE)

Safety and Efficacy Study of Eculizumab in Patients With Refractory Generalized Myasthenia Gravis

A Study in Moderate to Severe Rheumatoid Arthritis Participants

Advanced MRI Applications for Mild Traumatic Brain Injury-Phase 2

Pembrolizumab in Treating Patients With Relapsed or Refractory Stage IB-IVB Mycosis Fungoides or Sezary Syndrome

Open Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of CUDC-907 in Subjects With Advanced/Relapsed Solid Tumors

Other Conditions in Los Angeles